StockData
Novartis AG logo

Novartis AG

NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Feb 4, 2026Score 7/30
$160.79−0.31 (-0.19%)

Close on Oct 30, 2026Market cap $306.81BP/E 22.5Yield –

Novartis USD Growth in Rest of World by Quarter

USD Growth in Rest of World (% USD) (%)

QuarterlyAnnual

Novartis USD Growth in Rest of World: 3.0% in Q3 2026, down 6.0 pts from a year earlier. That is the lowest of the 16 quarters on record here.

Latest, Q3 2026
3.0%
Period ended Sep 30, 2026
Change on a year earlier
-6.0 pts
9.0% in Q3 2025
History
16 quarters
Since Q3 2019
Sources
16
Documents cited below

Where the Q3 2026 figure comes from

“|| Lutathera | Oncology | GEP-NETs gastroenteropancreatic neuroendocrine tumors | 156 | 3 | 63 | 3 | 6 | 219 | 3 | 3”

Source: Novartis Form 6-K (0001114448-26-000014) ↗

Reported in Form 6-K & Form 20-F.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedUSD Growth in Rest of World (% USD) (%)Year on yearSource
Q3 2026Sep 30, 20263.0%-6.0 ptsNovartis Form 6-K (0001114448-26-000014) ↗
Q2 2026Jun 30, 20269.0%-3.0 ptsNovartis Form 6-K (0001114448-26-000012) ↗
Q1 2026Mar 31, 202611.0%+7.0 ptsNovartis Form 6-K (0001114448-26-000010) ↗
Q4 2025Dec 31, 20258.0%-10.0 ptsNovartis Form 6-K (0001114448-26-000007) ↗
Q3 2025Sep 30, 20259.0%-15.0 ptsNovartis Form 6-K (0001114448-25-000003) ↗
Q2 2025Jun 30, 202512.0%-4.0 ptsNovartis Form 6-K (0001370368-25-000012) ↗
Q1 2025Mar 31, 20254.0%-12.0 ptsNovartis Form 6-K (0001370368-25-000010) ↗
Q4 2024Dec 31, 202418.0%-4.0 ptsNovartis Form 6-K (0001370368-25-000007) ↗
Q3 2024Sep 30, 202424.0%-5.0 ptsNovartis Form 6-K (0001370368-24-000022) ↗
Q2 2024Jun 30, 202416.0%-10.0 ptsNovartis Form 6-K (0001370368-24-000019) ↗
Q1 2024Mar 31, 202416.0%-16.0 ptsNovartis Form 6-K (0001370368-24-000017) ↗
Q4 2023Dec 31, 202322.0%–Novartis Form 6-K (0001370368-24-000007) ↗
Q3 2023Sep 30, 202329.0%–Novartis Form 6-K (0001370368-23-000068) ↗
Q2 2023Jun 30, 202326.0%–Novartis Form 6-K (0001370368-23-000059) ↗
Q1 2023Mar 31, 202332.0%–Novartis Form 6-K (0001370368-23-000046) ↗
Q3 2019Sep 30, 2019156.0%–Novartis Form 6-K (0001370368-19-000062) ↗

Cite this data

StockData. (2026). Novartis USD Growth in Rest of World (%), quarterly Q3 2019–Q3 2026 [Data set]. Compiled from Novartis SEC filings and investor materials. https://stockdatahq.com/stocks/nvs/kpis/brand-lutathera-row-yoy-usd-pct

See every metric in the Novartis KPI table. Data updated Nov 2, 2026.